259 results on '"McCombe, Pamela"'
Search Results
2. Transient binocular vision loss and pain insensitivity in Klippel–Feil syndrome: a case report
3. Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies
4. The role of epigenetic mechanisms and processes in autoimmune disorders
5. Proteomic investigation of ALS motor cortex identifies known and novel pathogenetic mechanisms
6. Polygenic risk score analysis for amyotrophic lateral sclerosis leveraging cognitive performance, educational attainment and schizophrenia
7. Impaired signaling for neuromuscular synaptic maintenance is a feature of Motor Neuron Disease
8. Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1
9. Neutrophil-to-lymphocyte ratio at diagnosis as a biomarker for survival of amyotrophic lateral sclerosis.
10. Potential mechanisms to modify impaired glucose metabolism in neurodegenerative disorders
11. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
12. Cytokines as a marker of central nervous system autoantibody associated epilepsy
13. The spectrum of language impairments in amyotrophic lateral sclerosis
14. Verbal and nonverbal fluency in amyotrophic lateral sclerosis.
15. General neurology: Current challenges and future implications.
16. Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome.
17. Mutations in heat shock protein beta-1 (HSPB1) are associated with a range of clinical phenotypes related to different patterns of motor neuron dysfunction: A case series
18. Plasma from some patients with amyotrophic lateral sclerosis exhibits elevated formaldehyde levels
19. The clinical profile of NMOSD in Australia and New Zealand
20. Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study
21. Comparative efficacy of ofatumumab versus oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons.
22. Variation in Resting Metabolic Rate Affects Identification of Metabolic Change in Geographically Distinct Cohorts of Patients With ALS.
23. Gut Symptoms, Gut Dysbiosis and Gut-Derived Toxins in ALS.
24. Associations of postprandial ghrelin, liver‐expressed antimicrobial peptide 2 and leptin levels with body composition, disease progression and survival in patients with amyotrophic lateral sclerosis.
25. Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a
26. Serial MRI studies over 12 months using manual and atlas-based region of interest in patients with amyotrophic lateral sclerosis
27. Significant out-of-sample classification from methylation profile scoring for amyotrophic lateral sclerosis
28. A missense mutation in the MLKL brace region promotes lethal neonatal inflammation and hematopoietic dysfunction
29. Longitudinal changes in intrinsic motoneuron excitability in amyotrophic lateral sclerosis are dependent on disease progression.
30. Takotsubo Cardiomyopathy in Myasthenic Crisis
31. Tract integrity in amyotrophic lateral sclerosis: 6–month evaluation using MR diffusion tensor imaging
32. Sensitivity and specificity of the ECAS in identifying executive function and social cognition deficits in MND.
33. Circulating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: Effect on outcome
34. The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in pathogenesis
35. Clinical features and impact of myasthenia gravis disease in Australian patients
36. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies
37. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations
38. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy
39. Marginal reversible jump Markov chain Monte Carlo with application to motor unit number estimation
40. Killer immunoglobulin-like receptor and their HLA ligands in Guillain–Barré Syndrome
41. Use of Bayesian MUNE to show differing rate of loss of motor units in subgroups of ALS
42. Quantitative studies of lower motor neuron degeneration in amyotrophic lateral sclerosis: Evidence for exponential decay of motor unit numbers and greatest rate of loss at the site of onset
43. Case report: Adult-onset limb girdle muscular dystrophy in sibling pair due to novel homozygous LAMA2 missense variant.
44. Phenotypic variability within the desminopathies: A case series of three patients.
45. Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis.
46. Age of Onset and Length of Survival of Queensland Patients with Amyotrophic Lateral Sclerosis: Details of Subjects with Early Onset and Subjects with Long Survival.
47. Prolonged elevation of cytokine levels after human acute ischaemic stroke with evidence of individual variability
48. Frequency and function of regulatory T cells after ischaemic stroke in humans
49. Direct evidence of intra- and interhemispheric corticomotor network degeneration in amyotrophic lateral sclerosis: An automated MRI structural connectivity study
50. Role of gender in multiple sclerosis: Clinical effects and potential molecular mechanisms
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.